2018
DOI: 10.1038/s41591-018-0325-y
|View full text |Cite
|
Sign up to set email alerts
|

Publisher Correction: Ultraviolet radiation–induced DNA damage is prognostic for outcome in melanoma

Abstract: In the version of this article originally published, Extended Data Fig. 3 was incorrect. A duplicate of Extended Data Fig. 4 was uploaded in place of Extended Data Fig. 3. Extended Data Fig. 3 has now been uploaded. The error has been fixed in the PDF and HTML versions of this article.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2020
2020
2021
2021

Publication Types

Select...
4
1
1

Relationship

1
5

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…An interesting output of this sequencing effort is the statistical analysis of the databank that made possible the determination of mutational signatures 193,194 available on-line from the COSMIC consortium 195 . Signatures bearing mutations at bipyrimidine sites (Table 7.2) are observed with a high frequency in melanoma 190,[196][197][198][199] , basal cell carcinoma 200,201 , squamous cell carcinoma 202 and cutaneous T cell lymphoma 203 . They are basically absent from other cancer types.…”
Section: Next Generation Sequencing Of Human Tumoursmentioning
confidence: 99%
“…An interesting output of this sequencing effort is the statistical analysis of the databank that made possible the determination of mutational signatures 193,194 available on-line from the COSMIC consortium 195 . Signatures bearing mutations at bipyrimidine sites (Table 7.2) are observed with a high frequency in melanoma 190,[196][197][198][199] , basal cell carcinoma 200,201 , squamous cell carcinoma 202 and cutaneous T cell lymphoma 203 . They are basically absent from other cancer types.…”
Section: Next Generation Sequencing Of Human Tumoursmentioning
confidence: 99%
“…Melanoma and lung cancer are the most mutated cancers [20], which is why patients suffering from these diseases benefit from immunotherapy to a higher extent than other cancer patients [21]. In melanoma, some UV-induced DNA damage is also prognostic for outcome [22].…”
Section: Tumor Mutational Burden (Tmb) As An Indicator For Predicting Response To Immunotherapymentioning
confidence: 99%